Edoxaban for stroke prevention in patients with atrial fibrillation: Of randomized and real-world evidence.

Indian Pacing Electrophysiol J · 2026 · PMC12958045 · PMID 41338415

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

showed a trendp = 0.06so close (0.05 < p ≤ 0.1)

For the primary safety outcome of major bleeding, the high-dose DOAC regimens showed a trend toward lower bleeding (RR 0.86, 95 % CI 0.73–1.00, p = 0.06).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.